GlassScriptPhysician profile
Joshua Heiman
NPI 1740743434
$26,503.72
in general payments reported to CMS, 2019-2025
13 companies · $822 in 2025
The $822 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $542 · 2024: $25K · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Food and Beverage: $1,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,000.00 |
| Food and Beverage | $1,503.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25,566.36 | 2023-2024 | Ams 700, Rezum Generator |
| Calyxo, INC. | $262.56 | 2025 | Cvac Aspiration System |
| Dornier Medtech America, INC | $168.99 | 2025 | Dornier Medtech |
| Valencia Technologies Corporation | $155.19 | 2025 | Ecoin Device Kit |
| Ambu INC. | $115.34 | 2024 | |
| Richard Wolf Medical Instruments Corp. | $95.20 | 2025 | |
| Abbvie INC. | $35.83 | 2025 | |
| Coloplast Corp | $21.91 | 2025 | |
| Janssen Biotech, INC. | $17.93 | 2025 | Erleada |
| Tolmar, INC. | $17.54 | 2025 | Jatenzo, Eligard |
| Abc Home Medical Supply, INC. | $16.98 | 2025 | |
| Profound Medical Corp. | $15.22 | 2025 | Tulsa-Pro |
| Urogen Pharma, INC. | $14.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Heiman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.